Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chu, Ching-Wen
Chien, Wu-Chien
Chung, Chi-Hsiang
Chao, Pei-Chun
Chang, Hsin-An
Kao, Yu-Chen
Chou, Yu-Ching
and
Tzeng, Nian-Sheng
2018.
Electroconvulsive Therapy and Risk of Dementia—A Nationwide Cohort Study in Taiwan.
Frontiers in Psychiatry,
Vol. 9,
Issue. ,
Hsiao, Ming-Hung
Yeh, Ta-Chuan
Ku, Shih-Chieh
Tseng, Yu-Ting
and
Liang, Chih-Sung
2019.
Cumulative Electroconvulsive Therapy–Associated Severe Hyperammonemic Encephalopathy: A Case Report.
American Journal of Therapeutics,
Vol. 26,
Issue. 6,
p.
e784.
Li, Ming
Yao, Xiaoxiao
Sun, Lihua
Zhao, Lihong
Xu, Wenbo
Zhao, Haisheng
Zhao, Fangyi
Zou, Xiaohan
Cheng, Ziqian
Li, Bingjin
Yang, Wei
and
Cui, Ranji
2020.
Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism.
Frontiers in Psychology,
Vol. 11,
Issue. ,
Watts, Bradley V.
Peltzman, Talya
and
Shiner, Brian
2021.
Mortality after electroconvulsive therapy.
The British Journal of Psychiatry,
Vol. 219,
Issue. 5,
p.
588.
Hajak, Vivien L.
Hajak, Göran
Ziegelmayer, Christoph
Grimm, Simone
and
Trapp, Wolfgang
2021.
Risk Assessment of Electroconvulsive Therapy in Clinical Routine: A 3-Year Analysis of Life-Threatening Events in More Than 3,000 Treatment Sessions.
Frontiers in Psychology,
Vol. 12,
Issue. ,
Huang, Jing-Syuan
Yang, Fu-Chi
Chien, Wu-Chien
Yeh, Ta-Chuan
Chung, Chi-Hsiang
Tsai, Chia-Kuang
Tsai, Shih-Jen
Yang, Sung-Sen
Tzeng, Nian-Shen
Chen, Mu-Hong
and
Liang, Chih-Sung
2021.
Risk of Substance Use Disorder and Its Associations With Comorbidities and Psychotropic Agents in Patients With Autism.
JAMA Pediatrics,
Vol. 175,
Issue. 2,
p.
e205371.
Karrouri, Rabie
Hammani, Zakaria
Benjelloun, Roukaya
and
Otheman, Yassine
2021.
Major depressive disorder: Validated treatments and future challenges.
World Journal of Clinical Cases,
Vol. 9,
Issue. 31,
p.
9350.
Liang, Chih-Sung
Bai, Ya-Mei
Hsu, Ju-Wei
Huang, Kai-Lin
Chu, Che-Sheng
Yeh, Ta-Chuan
Tsai, Shih-Jen
Chen, Tzeng-Ji
and
Chen, Mu-Hong
2022.
The Risk of Alzheimer's Disease After Acute Appendicitis With or Without Appendectomy.
Journal of the American Medical Directors Association,
Vol. 23,
Issue. 4,
p.
601.
Osler, Merete
Rozing, Maarten P.
Jorgensen, Martin B.
and
Jorgensen, Anders
2022.
Mortality and acute somatic events following electroconvulsive therapy in patients with pre-existing somatic comorbidity – A register-based nationwide Danish cohort study.
The World Journal of Biological Psychiatry,
Vol. 23,
Issue. 4,
p.
318.
Stella, Florindo
Radanovic, Márcia
Gallucci-Neto, José
and
Forlenza, Orestes Vicente
2023.
Electroconvulsive therapy for treating patients with agitation and related behavioral disorders due to dementia: a systematic review.
Dementia & Neuropsychologia,
Vol. 17,
Issue. ,
McCutchen, Thomas M.
Gligorovic, Predrag V.
Tighe, Nathaniel T.G.
Templeton, T. Wesley
and
Saha, Amit K.
2023.
Alfentanil Pretreatment for Electroconvulsive Therapy–Associated Hemodynamic Lability.
The Journal of ECT,
Vol. 39,
Issue. 2,
p.
84.
Lindblad, L.
Nordenskjöld, A.
Otterbeck, A.
and
Nordenskjöld, A.M.
2023.
Risk factors for mortality of medical causes within 30 days of electroconvulsive therapy.
Journal of Affective Disorders,
Vol. 320,
Issue. ,
p.
527.
Tian, Y.E.
Mengtao, X.U.
Jingpeng, F.A.N.G.
Qinxuan, W.U.
Xiaoyan, Z.O.U.
Fangqin, Y.A.N.
and
Zhixing, Q.I.N.G.
2023.
Antidepressant-like active ingredients and their related mechanisms of functional foods or medicine and food homologous products.
Digital Chinese Medicine,
Vol. 6,
Issue. 1,
p.
9.
von Mücke-Heim, Iven-Alex
Pape, Julius C.
Grandi, Norma C.
Erhardt, Angelika
Deussing, Jan M.
and
Binder, Elisabeth B.
2024.
Multiomics and blood-based biomarkers of electroconvulsive therapy in severe and treatment-resistant depression: study protocol of the DetECT study.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 274,
Issue. 3,
p.
673.
Comments
No Comments have been published for this article.